NOS2 and ovarian carcinoma: Further studies on a large group of patients including a study on the histopathological variability of ovarian cancer and the determination of the molecular interplay between iNOS and various cancer cell-related signaling pathways are necessary to resolve the question of whether iNOS is beneficial or detrimental in ovarian cancer.